Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Yoshioka

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Intractable & Rare Diseases Research|September 2, 2024
Splenectomy unveils thrombocytosis in underlying myeloproliferative neoplasms with extrahepatic portal vein obstructionTetsuya Shimizu, Hiroshi Yoshida, Nobuhiko Taniai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 19, 2008
[Antitumor effect of paclitaxel for gastric cancer is AUC dependent]Takeshi Yamada, Noritake Tanaka, Kiyonori Furukawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 15, 2007
[Three advanced gastric cancer patients successfully treated by combination therapy of paclitaxel and cisplatin]Takeshi Yamada, Noritake Tanaka, Kimiyoshi Yokoi, et al.
The Journal of International Medical Research|August 10, 2023
Evaluation of splenic infarction ratio and platelet increase ratio after partial splenic artery embolizationJunji Ueda, Yasuhiro Mamada, Nobuhiko Taniai, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|December 10, 2023
Distribution of Splenic Arterial Flow and Segmental Spleen Volume for Partial Splenic Arterial EmbolizationJunji Ueda, Yasuhiro Mamada, Nobuhiko Taniai, et al.
World Journal of Gastroenterology|December 11, 2025
Prognostic factors for peritoneovenous shunt placement for refractory ascites in liver cirrhosisAkira Hamaguchi, Junji Ueda, Nobuhiko Taniai, et al.
World Journal of Gastroenterology|January 19, 2026
Utility of liver surface-guided encirclement of hepatoduodenal ligament for the Pringle maneuver in minimally invasive repeat liver resectionYoichi Kawano, Takahiro Murokawa, Yuto Aoki, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Intractable & Rare Diseases Research|September 2, 2024
Splenectomy unveils thrombocytosis in underlying myeloproliferative neoplasms with extrahepatic portal vein obstructionTetsuya Shimizu, Hiroshi Yoshida, Nobuhiko Taniai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 19, 2008
[Antitumor effect of paclitaxel for gastric cancer is AUC dependent]Takeshi Yamada, Noritake Tanaka, Kiyonori Furukawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 15, 2007
[Three advanced gastric cancer patients successfully treated by combination therapy of paclitaxel and cisplatin]Takeshi Yamada, Noritake Tanaka, Kimiyoshi Yokoi, et al.
The Journal of International Medical Research|August 10, 2023
Evaluation of splenic infarction ratio and platelet increase ratio after partial splenic artery embolizationJunji Ueda, Yasuhiro Mamada, Nobuhiko Taniai, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|December 10, 2023
Distribution of Splenic Arterial Flow and Segmental Spleen Volume for Partial Splenic Arterial EmbolizationJunji Ueda, Yasuhiro Mamada, Nobuhiko Taniai, et al.
World Journal of Gastroenterology|December 11, 2025
Prognostic factors for peritoneovenous shunt placement for refractory ascites in liver cirrhosisAkira Hamaguchi, Junji Ueda, Nobuhiko Taniai, et al.
World Journal of Gastroenterology|January 19, 2026
Utility of liver surface-guided encirclement of hepatoduodenal ligament for the Pringle maneuver in minimally invasive repeat liver resectionYoichi Kawano, Takahiro Murokawa, Yuto Aoki, et al.
Pageof 12